Endovascular treatment with the Enterprise stent versus the Neuroform or Low-Profile Visualized Intraluminal Support stent for unruptured aneurysms.
J Comp Eff Res
; 10(4): 295-305, 2021 03.
Article
en En
| MEDLINE
| ID: mdl-33595342
ABSTRACT
Aim:
To compare outcomes among patients undergoing endovascular treatment for unruptured intracranial aneurysm (UIA) with the Enterprise stent versus the Neuroform or Low-Profile Visualized Intraluminal Support (LVIS) stent. Patients &methods:
Patients undergoing endovascular procedure for UIA were classified into Enterprise stent and Neuroform or LVIS stent group. Groups were propensity-score matched and generalized estimating equations were used for outcomes assessment.Results:
There were no significant between-group differences in length of stay or mortality. The Enterprise group had significantly lower odds of UIA-related inpatient readmissions versus the Neuroform/LVIS group (odds ratio 0.62; 95% CI 0.42-0.91).Conclusion:
Enterprise stent use was associated with significantly lower readmissions versus competitor stent, with no difference in other study outcomes.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Aneurisma Intracraneal
/
Embolización Terapéutica
/
Procedimientos Endovasculares
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
J Comp Eff Res
Año:
2021
Tipo del documento:
Article
País de afiliación:
Estados Unidos